Skip to NavigationSkip to content

Pharmafile - Business Services News

Kodak has been cleared of insider trading by an independent review after one of its top executives bought shares before a stock surge following the...
The coronavirus news this week focuses on lockdowns and infections, as England is set to increase lockdown restrictions across the country after a...
Smith previously became a lobbyist for Pfizer in 2005, and endorsed a company-backed report offering NHS patients easier access to private...
The European Commission has approved Heplcudex (bulvirtide) as the first hepatitis D drug.
The US will pay Johnson and Johnson more than $1 billion to create 100 million doses of COVID-19 vaccine.
Democratic members of Congress are set to investigate the Trump administration’s $765 million federal loan awarded to Kodak as it takes steps into...
The National Institutes of Health and Care Excellence has released its first guideline on the treatment of chronic pain and has said GPs should not...
Celltrion's infliximab biosimilar Remsima scores approval for five different indications in Europe, UK Government secures 60 million doses of GSK and...
Hydroxychloroquine continues its downwards spiral as Moderna's COVID vaccine secures a futher $472 million investment from the US Government. Read...
As the coronavirus pandemic shows no signs of slowing down, an Israeli doctor has appeared to have contracted COVID-19 for a second time after they...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches